NCT07259928 Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion Status RECRUITING Phase PHASE2
NCT07235085 A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy Status RECRUITING Phase PHASE3
NCT07230184 To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR Status COMPLETED Phase PHASE4
NCT06817265 Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy Status RECRUITING Phase PHASE3
NCT06713720 Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy Status RECRUITING Phase NA
NCT06487845 A Study to Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants Status COMPLETED Phase PHASE1
NCT05695417 Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05393284 Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05066230 A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR) Status TERMINATED Phase PHASE3
NCT04511715 Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy Status UNKNOWN Phase PHASE2/PHASE3
NCT04000789 The Effect of Combination of Vitamin A, Vitamin E, Sodium Hyaluronate 0.15% Eye Drop Compared With Sodium Hyaluronate 0.1% Eye Drop to Tear Film Stability and Conjunctival Goblet Cells Density in Patient With Non-Proliferative Diabetic Retinopathy (NPDR), and Proliferative Diabetic Retinopathy (PDR) Status UNKNOWN Phase NA
NCT02435862 A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy Status COMPLETED Phase PHASE2
NCT02388984 Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy Status UNKNOWN Phase PHASE3
NCT02096874 Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema Status COMPLETED Phase PHASE4
NCT02062034 Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy Status COMPLETED Phase PHASE2